Pimonidazole clinical trials
Includes 3 studies of Pimonidazole hydrochloride.
- studies test it
- 9
- open now
- 0
- in phase 3
- 0
- first study started
- 2006
How each study uses pimonidazole is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- Pimonidazole
- 6
Studies by the year they started
9 studies that test it; most in 2014 (3)
| Year | Studies |
|---|---|
| 2006 | 1 |
| 2014 | 3 |
| 2015 | 1 |
| 2018 | 3 |
| 2021 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 0 · Other 9
University Health Network, Toronto (3) · H. Lee Moffitt Cancer Center and Research Institute (2) · Thomas Gleason (1) · Sunnybrook Health Sciences Centre (1) · Marius Gustav Bredell (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses pimonidazole is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 9
- FAZA PET/MRI SarcomaActive, not recruitingNot applicableUniversity Health Network, TorontoNCT03418818Written as Pimonidazole
- Prostate Hypoxia - TICActive, not recruitingNot applicableUniversity Health Network, TorontoNCT02095249Written as Pimonidazole
- Detection of Hypoxia in Human Thoracic Aorta Using Pimonidazole HydrochlorideCompletedPhase 1Thomas GleasonNCT03410420Written as Pimonidazole hydrochloride
- Correlation of FAZA PET Hypoxia Imaging To 3D Histology in Oral Tongue CancerSuspendedPhase 1/2Sunnybrook Health Sciences CentreNCT03181035Written as Pimonidazole
- Total Tumor Mapping (TTM) for Resectable Pancreatic CancerWithdrawnEarly Phase 1H. Lee Moffitt Cancer Center and Research InstituteNCT03718650Written as Pimonidazole
- Novel Window of Opportunity Trial to Evaluate the Impact of Statins to Oppose Prostate CancerCompletedPhase 2University Health Network, TorontoNCT01992042Written as Pimonidazole
- Pimonidazole Hydrochloride to Detect Low Oxygen in Tuberculosis-Infected LungsWithdrawnPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT00374517Written as Pimonidazole hydrochloride
- Hypoxia Analysis in Head and/or Neck CancerStatus unknownPhase 2Marius Gustav BredellNCT02414048Written as Pimonidazole
- Biomarker Correlates of Hypoxia in Metastatic MelanomaWithdrawnPhase 2H. Lee Moffitt Cancer Center and Research InstituteNCT02061007Written as Pimonidazole hydrochloride (Hypoxyprobe™-1)
Codes
What other systems call pimonidazole · ClinicalTrials.gg INT003015
- MeSH (NLM) C033815pimonidazoleConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 46JO4D76R2PIMONIDAZOLEConfirmed FDA, NLM, Wikidata
- Wikidata Q27258937pimonidazoleConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C1196PimonidazoleOne source FDA
- DrugBank DB12485One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C033815 | pimonidazole | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 46JO4D76R2 | PIMONIDAZOLE | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q27258937 | pimonidazole | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C1196 | Pimonidazole | One source FDA |
| DrugBank | DB12485 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.